Evaluation of Digoxin Bioavailability in Single-Dose Studies
- 27 September 1973
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (13), 651-654
- https://doi.org/10.1056/nejm197309272891302
Abstract
Methods for testing digoxin bioavailability were compared in single-dose crossover studies using eight healthy male subjects. Digoxin (0.75 mg) was given by intravenous infusion, intramuscular injection, oral elixir and oral tablet. Multiple serum concentrations and six-day cumulative urinary excretion were determined after each mode of administration.Keywords
This publication has 15 references indexed in Scilit:
- RATE OF DISSOLUTION OF DIGOXIN TABLETS AS A PREDICTOR OF ABSORPTIONThe Lancet, 1973
- CORRELATION OF DIGOXIN-TABLET DISSOLUTION-RATE WITH BIOLOGICAL AVAILABILITYThe Lancet, 1973
- Comparative Study of the Absorption, Plasma Levels, and Urinary Excretion of the "New" and the "Old" LanoxinBMJ, 1973
- BIOAVAILABILITY OF DIGOXINThe Lancet, 1973
- The Absorption of Orally Administered [12α-3H]Digoxin in ManClinical Science, 1972
- BIOAVAILABILITY OF DIGOXINThe Lancet, 1972
- BIOAVAILABILITY OF DIGOXINThe Lancet, 1972
- NEW FORMULATION OF LANOXIN: EXPECTED PLASMA LEVELS OF DIGOXINThe Lancet, 1972
- VARIATION IN THE BIOLOGICAL AVAILABILITY OF DIGOXINThe Lancet, 1972
- Variation in Biologic Availability of Digoxin from Four PreparationsNew England Journal of Medicine, 1971